3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
venetoclax
46
Specimen Handling
35
Azacitidine
35
Cytarabine
32
fludarabine
23
Biopsy
23
Cyclophosphamide
18
decitabine and cedazuridine drug combination
14
Injections
14
Daunorubicin
14
fludarabine phosphate
13
Whole-Body Irradiation
11
Busulfan
11
Mycophenolic Acid
10
Melphalan
10
Tacrolimus
9
Idarubicin
9
CPX-351
9
ivosidenib
8
Stem Cell Transplantation
8
Granulocyte Colony-Stimulating Factor
8
Gemtuzumab
7
Decitabine
7
Cyclosporine
7
enasidenib
6
X-Rays
6
Magnetic Resonance Spectroscopy
6
Filgrastim
6
olutasidenib
5
gilteritinib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Acute
×
olverembatinib
×
30 days
×
Clear all
No trials found.